TipRanks
Advertisement
Advertisement

HK:2181 Stock Latest News

Mabpharm Posts Tenfold Profit Surge on Strong Revenue Growth in First Half 2026
Company AnnouncementsMabpharm Posts Tenfold Profit Surge on Strong Revenue Growth in First Half 2026
24d ago
2181
Mabpharm Sets August Board Meeting to Approve 2026 Interim Results
PremiumCompany Announcements
Mabpharm Sets August Board Meeting to Approve 2026 Interim Results
1M ago
2181
Mabpharm Shareholders Unanimously Approve All AGM Resolutions
PremiumCompany Announcements
Mabpharm Shareholders Unanimously Approve All AGM Resolutions
3M ago
2181
Mabpharm Wins NMPA Nod for New Denosumab Injection, Eyes Rapid Market Expansion
PremiumCompany Announcements
Mabpharm Wins NMPA Nod for New Denosumab Injection, Eyes Rapid Market Expansion
3M ago
2181
Mabpharm Wins China Approval for Denosumab Osteoporosis Drug, Eyes Global Markets
PremiumCompany Announcements
Mabpharm Wins China Approval for Denosumab Osteoporosis Drug, Eyes Global Markets
3M ago
2181
Mabpharm Sets 2026 AGM, Seeks 10% Share Buyback Mandate
PremiumCompany AnnouncementsMabpharm Sets 2026 AGM, Seeks 10% Share Buyback Mandate
5M ago
2181
Mabpharm Moves to Update Constitution for Treasury Shares and Digital Governance
Premium
Company Announcements
Mabpharm Moves to Update Constitution for Treasury Shares and Digital Governance
6M ago
2181
Mabpharm Swings to Profit on Surging 2025 Revenue and Strong Gross Margins
Premium
Company Announcements
Mabpharm Swings to Profit on Surging 2025 Revenue and Strong Gross Margins
6M ago
2181
Mabpharm Sets March 26 Board Meeting to Approve 2025 Annual Results
PremiumCompany Announcements
Mabpharm Sets March 26 Board Meeting to Approve 2025 Annual Results
6M ago
2181
Mabpharm Limited Announces Board and Committee Restructuring
PremiumCompany Announcements
Mabpharm Limited Announces Board and Committee Restructuring
11M ago
2181
Mabpharm Limited Updates Nomination Committee Terms
PremiumCompany Announcements
Mabpharm Limited Updates Nomination Committee Terms
11M ago
2181
Mabpharm Limited Reports Strong Interim Financial Results for H1 2025
PremiumCompany Announcements
Mabpharm Limited Reports Strong Interim Financial Results for H1 2025
1y ago
2181
Mabpharm Limited Schedules Board Meeting for Interim Results
PremiumCompany AnnouncementsMabpharm Limited Schedules Board Meeting for Interim Results
1y ago
2181
Mabpharm Limited Announces Unanimous Approval of AGM Resolutions
Premium
Company Announcements
Mabpharm Limited Announces Unanimous Approval of AGM Resolutions
1y ago
2181
Mabpharm Limited Announces 2025 Annual General Meeting and Share Repurchase Proposal
Premium
Company Announcements
Mabpharm Limited Announces 2025 Annual General Meeting and Share Repurchase Proposal
1y ago
2181
Mabpharm Limited Reports Significant Revenue Growth Amidst Financial Challenges
PremiumCompany Announcements
Mabpharm Limited Reports Significant Revenue Growth Amidst Financial Challenges
1y ago
2181
Mabpharm Limited Schedules Board Meeting for Annual Results Review
PremiumCompany Announcements
Mabpharm Limited Schedules Board Meeting for Annual Results Review
2y ago
2181
Mabpharm Gains Approval in Pakistan for Key Drug
PremiumCompany Announcements
Mabpharm Gains Approval in Pakistan for Key Drug
2y ago
2181
Mabpharm Gains Indonesian Approval for Key Drug
PremiumCompany Announcements
Mabpharm Gains Indonesian Approval for Key Drug
2y ago
2181
Mabpharm Ends Lease Early for Strategic Growth
PremiumCompany AnnouncementsMabpharm Ends Lease Early for Strategic Growth
2y ago
2181
Mabpharm Limited Reports Mixed Mid-Year Results
Premium
Company Announcements
Mabpharm Limited Reports Mixed Mid-Year Results
2y ago
2181
Mabpharm Limited Announces Upcoming Board Meeting
Premium
Company Announcements
Mabpharm Limited Announces Upcoming Board Meeting
2y ago
2181

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >